世界中医药
世界中醫藥
세계중의약
WORLD CHINESE MEDICINE
2015年
1期
73-74,79
,共3页
邹佩霞%李莉%刘兴林%陈德森
鄒珮霞%李莉%劉興林%陳德森
추패하%리리%류흥림%진덕삼
通痹外敷散%膝关节炎%细胞介素-1β亚型%透明质酸
通痺外敷散%膝關節炎%細胞介素-1β亞型%透明質痠
통비외부산%슬관절염%세포개소-1β아형%투명질산
Tongbi external powder%Knee arthritis%Interleukin-1 subtype%Hyaluronic acid
目的:观察中药通痹外敷散对弗氏完全佐剂性大鼠急性关节炎的影响,探讨其作用机制。方法:大鼠随机分为模型组及治疗组,分别于右膝关节腔内注弗氏完全佐剂0.1 mL,术前及术后1周、2周、3周分别测定白细胞介素-1β亚型( IL-1β)、透明质酸( HA)含量;测量右足趾关节以下部位的容积,计算各组治疗效果。结果:治疗2周后,治疗组IL-1β明显降低、HA含量明显升高,与治疗前及模型组比较有统计学意义( P<0.05)。治疗组足肿胀度及消肿时间明显优于模型组( P<0.05)。结论:通痹外敷散能有效治疗弗氏完全佐剂性大鼠急性关节炎,其作用可能是通过抑制IL-1β合成、增加HA含量而起到治疗作用。
目的:觀察中藥通痺外敷散對弗氏完全佐劑性大鼠急性關節炎的影響,探討其作用機製。方法:大鼠隨機分為模型組及治療組,分彆于右膝關節腔內註弗氏完全佐劑0.1 mL,術前及術後1週、2週、3週分彆測定白細胞介素-1β亞型( IL-1β)、透明質痠( HA)含量;測量右足趾關節以下部位的容積,計算各組治療效果。結果:治療2週後,治療組IL-1β明顯降低、HA含量明顯升高,與治療前及模型組比較有統計學意義( P<0.05)。治療組足腫脹度及消腫時間明顯優于模型組( P<0.05)。結論:通痺外敷散能有效治療弗氏完全佐劑性大鼠急性關節炎,其作用可能是通過抑製IL-1β閤成、增加HA含量而起到治療作用。
목적:관찰중약통비외부산대불씨완전좌제성대서급성관절염적영향,탐토기작용궤제。방법:대서수궤분위모형조급치료조,분별우우슬관절강내주불씨완전좌제0.1 mL,술전급술후1주、2주、3주분별측정백세포개소-1β아형( IL-1β)、투명질산( HA)함량;측량우족지관절이하부위적용적,계산각조치료효과。결과:치료2주후,치료조IL-1β명현강저、HA함량명현승고,여치료전급모형조비교유통계학의의( P<0.05)。치료조족종창도급소종시간명현우우모형조( P<0.05)。결론:통비외부산능유효치료불씨완전좌제성대서급성관절염,기작용가능시통과억제IL-1β합성、증가HA함량이기도치료작용。
Objective:To observe effect of Tongbi Application Powder on Freund’s adjuvant knee arthritis in rats and its mecha-nism.Methods:Rats were randomly divided into model group and treatment group, sc.injected Freund’s adjuvant 0.1ml into right knee, then measured interleukin-1 beta (IL-1 β), hyaluronic acid (HA) before surgery,1wk, 2wk, 3wk after surgery;measured volume below the right toe.Results:After wk2 , treatment group had lower IL-1 beta and higher HA levels, significantly different compared with that before treatment and model group ( P<0.05) .The treatment group’s extent of foot swelling and dura-tion was significantly better than that of model group, ( P<0.05) .Conclusion:Tongbi Application Powder is effective for treating Freund’s adjuvant arthritis in rats, the effect may be induced by inhibiting IL-1 βsynthesis and increasing HA level.